Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for AMED
25.34
-0.27 (-1.03%)
Nov 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.91 - 25.96
52 week 12.86 - 26.73
Open 25.88
Vol / Avg. 233,595.00/368,609.00
Mkt cap 846.03M
P/E     -
Div/yield     -
EPS -0.16
Shares 33.38M
Beta 0.86
Inst. own 99%
Oct 29, 2014
Q3 2014 Amedisys Inc Earnings Call - Webcast
Oct 29, 2014
Q3 2014 Amedisys Inc Earnings Release
Sep 3, 2014
Amedisys Inc at Robert W. Baird & Co. Inc Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 2.86% -7.58%
Operating margin 5.41% -12.40%
EBITD margin - 3.35%
Return on average assets 4.95% -13.00%
Return on average equity 8.96% -22.58%
Employees 14,300 -
CDP Score - -

Address

5959 S SHERWOOD FOREST BLVD
BATON ROUGE, LA 70816
United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amedisys, Inc. (Amedisys) is a health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and their families, with approximately 11 million visits per year. The Company operates in two segments: home health and hospice. The Company's home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgical procedure. Amedisys�s hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. As of December 31, 2011, it owned and operated 440 Medicare-certified home health care centers, 87 Medicare-certified hospice care centers and two hospice inpatient units in 41 states within the United States, the District of Columbia and Puerto Rico. On November 1, 2011, it acquired Hospice of Hackensack University Medical Center (Hackensack Hospice). On June 7, 2011, Amedisys acquired Beacon Hospice, Inc.

Officers and directors

Ronald A. LaBorde President, Interim Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Dale E. Redman Interim Chief Financial Officer
Age: 66
Bio & Compensation  - Reuters
Jeffrey D. Jeter Chief Compliance Officer
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David R. Bucey General Counsel, Corporate Secretary
Age: 56
Bio & Compensation  - Reuters
Michael O. Fleming M.D. Chief Medical Officer
Age: 63
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Nathaniel M. Zilkha Director
Age: 38
Bio & Compensation  - Reuters
Linda J. Hall Independent Director
Age: 65
Bio & Compensation  - Reuters
Jake L. Netterville Independent Director
Age: 76
Bio & Compensation  - Reuters
Peter F. Ricchiuti Independent Director
Age: 57
Bio & Compensation  - Reuters